ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer
Acta Oncologica
◽
10.1080/0284186x.2020.1851045
◽
2020
◽
pp. 1-8
Author(s):
Anne Sofie Brems-Eskildsen
◽
Søren Linnet
◽
Hella Danø
◽
Adam Luczak
◽
Peter Michael Vestlev
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Phase 2
◽
Oral Capecitabine
◽
Phase 2 Study
◽
Metronomic Treatment
◽
Randomized Phase 2
Download Full-text
Related Documents
Cited By
References
Randomized phase 2 study of abiraterone acetate (AA) with or without exemestane (E) in postmenopausal patients (pts) with estrogen receptor–positive (ER+) metastatic breast cancer (MBC).
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.519
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. 519-519
◽
Cited By ~ 3
Author(s):
Joyce O'Shaughnessy
◽
Mario Campone
◽
Etienne Brain
◽
Patrick Neven
◽
Daniel F. Hayes
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Abiraterone Acetate
◽
Phase 2
◽
Phase 2 Study
◽
Estrogen Receptor Positive
◽
Randomized Phase 2
Download Full-text
Abstract S2-05: Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) withBRCA1orBRCA2mutations and metastatic breast cancer: A randomized, phase 2 study
10.1158/1538-7445.sabcs16-s2-05
◽
2017
◽
Cited By ~ 6
Author(s):
HS Han
◽
V Diéras
◽
ME Robson
◽
M Palácová
◽
PK Marcom
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Phase 2
◽
Phase 2 Study
◽
Randomized Phase 2
Download Full-text
Abstract P5-14-05: The impact of food on tolerability of abemaciclib in patients with previously treated hormone receptor-positive, HER2-negative, metastatic breast cancer: An open-label, randomized phase 2 study
10.1158/1538-7445.sabcs19-p5-14-05
◽
2020
◽
Author(s):
Elgene Lim
◽
Frances Boyle
◽
Meena Okera
◽
Sherene Loi
◽
Sema Sezgin Goksu
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Phase 2
◽
Open Label
◽
Hormone Receptor Positive
◽
Phase 2 Study
◽
Previously Treated
◽
The Impact
◽
Randomized Phase 2
Download Full-text
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial
Cancer
◽
10.1002/cncr.30141
◽
2016
◽
Vol 122
(19)
◽
pp. 2961-2970
◽
Cited By ~ 5
Author(s):
Jan C. Drooger
◽
Harm van Tinteren
◽
Steffen M. de Groot
◽
Albert J. ten Tije
◽
Hiltje de Graaf
◽
...
Keyword(s):
Breast Cancer
◽
Cancer Research
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Phase 2
◽
Her2 Positive
◽
Phase 2 Study
◽
Group Trial
◽
Randomized Phase 2
Download Full-text
Abstract OT2-3-07: A randomized, phase 2 study of the poly (ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888) in combination with temozolomide (TMZ) or in combination with carboplatin (C) and paclitaxel (P) versus placebo plus C/P in subjects withBRCA1orBRACA2mutation and metastatic breast cancer
10.1158/0008-5472.sabcs12-ot2-3-07
◽
2012
◽
Author(s):
SJ Isakoff
◽
S Pulhalla
◽
SP Shepherd
◽
N Falotico
◽
B Kaufman
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Parp Inhibitor
◽
Metastatic Breast
◽
Phase 2
◽
Phase 2 Study
◽
Randomized Phase 2
Download Full-text
101P Significant Antitumor Activity in A Randomized Phase 2 Study Comparing 2 Schedules of Nktr-102 In Patients (Pts) with Metastatic Breast Cancer (Mbc)
Annals of Oncology
◽
10.1016/s0923-7534(19)65752-2
◽
2012
◽
Vol 23
◽
pp. ii43
◽
Cited By ~ 2
Author(s):
A. Awada
◽
S. Chan
◽
G.H.M. Jerusalem
◽
R.E. Coleman
◽
M.T. Huizing
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Antitumor Activity
◽
Metastatic Breast
◽
Phase 2
◽
Phase 2 Study
◽
Randomized Phase 2
Download Full-text
Faculty Opinions recommendation of Abstract P6-11-12: Subgroup Analysis by prior treatment and disease burden in MONARCH 1: A phase 2 study of monotherapy abemaciclib, a CDK4 & 6 inhibitor, in patients with HR+/HER2 metastatic breast cancer (MBC) following chemotherapy.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.735553267.793559058
◽
2019
◽
Author(s):
Ahmad Awada
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Subgroup Analysis
◽
Disease Burden
◽
Metastatic Breast
◽
Prior Treatment
◽
Phase 2
◽
Phase 2 Study
Download Full-text
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2 ‐negative metastatic breast cancer
International Journal of Cancer
◽
10.1002/ijc.33613
◽
2021
◽
Author(s):
Hyehyun Jeong
◽
Jae Ho Jeong
◽
Jeong Eun Kim
◽
Jin‐Hee Ahn
◽
Kyung Hae Jung
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Hormone Receptor
◽
Metastatic Breast
◽
Protective Effects
◽
Phase 2
◽
Hormone Receptor Positive
◽
Randomized Phase 2
Download Full-text
A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer
Cancer
◽
10.1002/cncr.24900
◽
2010
◽
Vol 116
(6)
◽
pp. 1440-1445
◽
Cited By ~ 3
Author(s):
Gabriel N. Hortobagyi
◽
William Heim
◽
Laura Hutchins
◽
Edgardo Rivera
◽
Bernard Mason
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Fixed Combination
◽
Metastatic Breast
◽
Daily Regimen
◽
Phase 2
◽
Phase 2 Study
Download Full-text
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
Breast Cancer Research and Treatment
◽
10.1007/s10549-018-05070-2
◽
2018
◽
Vol 174
(2)
◽
pp. 433-442
◽
Cited By ~ 17
Author(s):
O. Nanni
◽
◽
D. Amadori
◽
A. De Censi
◽
A. Rocca
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Trial
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Line Treatment
◽
Phase 2
◽
First Line
◽
Phase 2 Clinical Trial
◽
Randomized Phase 2
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close